Trends in the Treatment of Uterine Leiomyosarcoma in the Medicare Population

ObjectiveUterine leiomyosarcoma (LMS) is a relatively rare malignancy that is associated with a poor prognosis. The rarity of LMS has led to a lack of consensus regarding appropriate treatment. The goal of this study was to identify the role that chemotherapy and radiotherapy have played in the trea...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of gynecological cancer 2015-03, Vol.25 (3), p.453-458
Hauptverfasser:	Foley, Olivia W., Rauh-Hain, J. Alejandro, Clemmer, Joel, Clark, Rachel M., Hall, Tracilyn, Diver, Elisabeth J., Schorge, John O., del Carmen, Marcela G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Factors Aged Antineoplastic Agents - therapeutic use Chemotherapy Chemotherapy, Adjuvant - trends Female Health Status Humans Leiomyosarcoma - pathology Leiomyosarcoma - therapy Medical prognosis Medicare Medicare - trends Neoplasm Staging Radiation therapy Radiotherapy, Adjuvant - trends SEER Program Survival Rate United States Uterine Neoplasms - pathology Uterine Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!